TABLE 4.
Odds ratios (and 95% CIs) from a logistic regression analysis of baseline adipokines as predictors of the development of the metabolic syndrome at the 3-y follow-up by tertile (T)1
| T1 | T2 | T3 | P for trend | |
| Adiponectin (μg/mL) | 2.42–11.04 | 11.19–18.47 | 18.66–41.08 | |
| Model 1 | 1.0 | 0.10 (0.01, 1.04) | 0.07 (0.01, 0.73) | 0.017 |
| Model 2 | 1.0 | 0.10 (0.01, 0.91) | 0.08 (0.01, 0.79) | |
| Model 3 | 1.0 | 0.27 (0.03, 2.65) | 0.15 (0.01, 1.76) | |
| Model 4 | 1.0 | 0.16 (0.02, 1.20) | 0.10 (0.01, 1.02) | |
| RBP4 (μg/mL) | 24.1–55.2 | 55.5–67.8 | 67.8–108.0 | |
| Model 1 | 1.0 | 5.42 (0.61, 48.04) | 4.25 (0.46, 39.31) | 0.252 |
| Model 2 | 1.0 | 5.31 (0.59, 47.42) | 3.12 (0.32, 30.86) | |
| Model 3 | 1.0 | 6.38 (0.58, 69.68) | 1.99 (0.17, 23.12) | |
| Model 4 | 1.0 | 9.93 (0.77–127.6) | 2.56 (0.29, 22.84) | |
| A-FABP (μg/L) | 5.0–11.0 | 12.0–17.0 | 18.0–43.0 | |
| Model 1 | 1.0 | 1.09 (0.06, 18.81) | 10.82 (1.15, 101.52) | 0.005 |
| Model 2 | 1.0 | 1.02 (0.06, 16.79) | 9.56 (1.15, 79.64) | |
| Model 3 | 1.0 | 1.29 (0.08, 21.47) | 12.00 (1.34, 107.36) | |
| Model 4 | 1.0 | 1.90 (0.08, 44.66) | 17.33 (1.25, 239.76) |
1
RBP4, retinol-binding protein 4; A-FABP, adipocyte fatty acid–binding protein. Model 1 was adjusted for Tanner stage; model 2 was adjusted for Tanner stage and homeostasis model assessment of insulin resistance (HOMA-IR) at baseline; model 3 was adjusted for Tanner stage, HOMA-IR at baseline, and BMI at baseline; and model 4 was adjusted for Tanner stage, sleep duration, physical activity, HOMA-IR at baseline, and BMI at baseline. The interaction models were not significant.